Director TitleAgeSince
Director/Board Member - 01/10/2010
Director/Board Member - 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
-63.82%-63.82% - - 2L
-2.81%+0.99%+20.98%+73.53% 5TCr
+1.14%+1.47%+59.54%+123.40% 4.03TCr
+0.56%+5.80%+19.04%+86.59% 1.22TCr
+0.98%-1.04%-10.47%+13.15% 1.2TCr
+0.57%+2.72%+31.59%+153.11% 924.83Cr
-0.15%-1.65%+27.65%+48.56% 761.82Cr
-0.39%+3.33%+28.41%+222.15% 735.54Cr
+1.43%+1.70%+50.00%-9.99% 720.79Cr
-0.13%+0.79%-36.70%+15.26% 525.95Cr
Average -6.26%+1.16%+21.11%+80.64% 1.68TCr
Weighted average by Cap. -0.43%+1.81%+29.33%+87.93%
Logo Pivotal Therapeutics Inc.
Pivotal Therapeutics Inc is a Canada-based specialty pharmaceutical company with a focus on optimizing Omega-3 therapy for cardiovascular disease and overall health. The Company's lead product VASCAZEN is used to correct an Omega-3 deficiency within eight weeks of treatment with positive concomitant effects on the lipid profiles, mainly a 48% reduction of triglycerides and an increase in high-density lipoprotein- Cholesterol (HDL-C) without a negative impact on the low density lipoprotein cholesterol (LDL-C) lipid profile. Its second product, OMAZEN is a greater than 90% pure, pharmaceutical grade Omega-3 commercialized for sale and distribution in Canada only for the maintenance of health.
Employees
-